Microfluidics Establishes PureNano™ Group (PNG) to Advance Continuous Manufacturing of Nanomaterials

Share Article

Nanotechnology-Based Drugs, Fine Chemicals and Materials for Energy Applications to Be Targeted

News Image
Our PureNano Technology is a leap forward for materials engineering in producing the purest, most uniform nano-sized substances available anywhere

Microfluidics, the exclusive global provider of Microfluidizer® high shear fluid processors, today launched a dedicated, internal PureNano Group (PNG) to develop go-to-market strategies for PureNano. This is an exclusive, award-winning, processing technology used to create tailored nanomaterials through crystallization, chemical reaction and nano-encapsulation. Applications of the technology include nanotechnology- based novel pharmaceuticals, functional foods and catalysts.

“Our PureNano Technology is a leap forward for materials engineering in producing the purest, most uniform nano-sized substances available anywhere,” said Thomai (Mimi) Panagiotou, Ph.D., Microfluidics Chief Technology Officer. “The PNG has the passion and commitment to advance PureNano’s technology, process consulting, training and implementations. I am confident that we will achieve new levels of product quality and process efficiency for the pharmaceutical market, the energy industry and beyond.”

Dr. Panagiotou will head the group. The PNG team will also include: MIT Chemical Engineering senior faculty member Robert J. Fisher, Ph.D., PureNano Engineering Manager Ken Chomistek and Microfluidics Global Sales Support Manager Tom Speed.

Over the next six months PNG’s business objectives will include:

  • Establishing PureNano customer interactions, services and implementation
  • Assuring that each PureNano unit is implemented successfully
  • Creating market knowledge about the technology’s capabilities
  • Developing and integrating a comprehensive sales training module

PureNano Technology
PureNano Technology, a cutting-edge platform for continuous manufacturing, combines a unique, high shear fluid processor with expert process development. It is a revolutionary technology for bottom-up nanoparticle creation offering:

  • Continuous crystallization for production of highly crystalline drug nanoparticles
  • Multi-phase chemical reactions
  • Nanoencapsulation of actives
  • Process intensification

With the goal of reducing the time and cost of commercial drug formulation, PureNano enables companies to transform their batch manufacturing efforts into continuous production processes. Through the bottom–up creation of nanoparticles, as well as the ability to control their growth, PureNano enables research teams to develop stable and consistent nanoemulsions of previously unattainable sizes and narrow distributions (such as Azithromycin with a z-average particle size of 82 nm).

About Microfluidics
Microfluidics, an IDEX company, is the exclusive producer of Microfluidizer® high shear fluid processors for uniform particle size reduction, robust cell disruption and bottom-up nanoparticle creation. Used primarily by pharmaceutical, biotechnology, chemical, cosmetic, nutraceutical/food and energy companies to research, develop and improve products with efficient processes, more than 3,000 Microfluidizer processors are installed at customer sites in 50 countries around the world. The innovative Microfluidics Technology Center, located at the company’s headquarters outside Boston, Mass., is staffed by expert engineers with a wide range of nanotechnology and application experience for Proof of Concept and Process Development services.

By producing smaller particle sizes and a more narrow distribution than other technologies, with scaleup from lab to production guaranteed, Microfluidics enables companies to create tiny particles that achieve big results. To learn more, visit http://www.microfluidicscorp.com.

Wendy Rogalinski
617-969-5452 ext. 240

Editorial Contact:
Barbara Rudolph    
Rudolph Communications, LLC

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Wendy Rogalinski
617.969.5452 240
Email >

Barbara Rudolph
Visit website